TTBK2

TTBK2 or Tau Tubulin Kinase 2 is an enzyme that in humans is encoded by the TTBK2 gene. This kinase belongs to a family of proteins known for their role in neurodegenerative diseases, particularly in the phosphorylation of tau proteins, which are implicated in the pathology of Alzheimer's disease and other tauopathies. TTBK2 has also been identified as playing a crucial role in the primary cilium's formation and function, an organelle important for cell signaling and sensory functions.

Function

TTBK2 is a serine/threonine kinase involved in various cellular processes, including microtubule dynamics, intracellular signaling, and cell division. It is particularly noted for its role in ciliogenesis, the process by which cells build primary cilia. The primary cilium is a sensory organelle found on the surface of most mammalian cells and is crucial for signal transduction pathways, including those of the Hedgehog signaling pathway, which is vital for embryonic development and tissue regeneration.

In the context of neurodegeneration, TTBK2 phosphorylates tau proteins, a process that can lead to the formation of neurofibrillary tangles, a hallmark of Alzheimer's disease and other tauopathies. The kinase's activity towards tau and other microtubule-associated proteins suggests its significant role in maintaining microtubule stability and dynamics.

Genetics

The TTBK2 gene is located on chromosome 15q15.3 in humans. Mutations in this gene have been associated with spinocerebellar ataxia type 11 (SCA11), a rare form of hereditary ataxia characterized by progressive loss of muscle coordination (ataxia) and in some cases, eye movement abnormalities. The disease's onset can vary from late childhood to adulthood, indicating the gene's role in both developmental and adult neurological processes.

Clinical Significance

The link between TTBK2 mutations and SCA11 highlights the importance of this kinase in neurological health. Understanding the molecular mechanisms by which TTBK2 mutations lead to neurodegeneration can provide insights into potential therapeutic targets for treating SCA11 and possibly other related neurodegenerative disorders.

Moreover, the role of TTBK2 in ciliogenesis and its implications in diseases beyond neurodegeneration, such as cystic kidney disease and retinal degeneration, underscore the enzyme's significance in a wide range of physiological and pathological processes.

Research Directions

Current research on TTBK2 is focused on elucidating its precise mechanisms of action in both the central nervous system and other tissues. Studies are also underway to explore the potential of targeting TTBK2 with small molecule inhibitors as a therapeutic strategy for diseases associated with its dysfunction, including Alzheimer's disease, SCA11, and ciliopathies.

See Also

• Tau protein
• Spinocerebellar ataxia
• Ciliopathy
• Hedgehog signaling pathway
• Microtubule

References

‎